Logo | Name | Σ | ||
---|---|---|---|---|
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3488 | 2603 | 833 | |
GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: Pharmaceutical | 1080 | 705 | 402 | |
DECATHLON FRANCE Move people through the wonders of sports. We are the world's Largest sports retailer. Founded in 1976, in France, we have set about making the pleasure and benefit of sports available for everyone across the globe. We do that by providing world class products at extremely affordable prices for all participants, from enthusiastic beginners to passionate professionals . Sports, Vente, and Conception Sectors: Retail and Distribution | 4233 | 2890 | 506 | |
Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: Pharmaceutical | 598 | 332 | 75 | |
MSC Mediterranean Shipping Company MSC is a privately owned global shipping company founded in 1970 by Gianluigi Aponte. As one of the world’s leading container shipping lines with headquarters in Geneva, Switzerland, MSC operates in over 675 offices across more than 155 countries worldwide with over 200,000 MSC Group employees. With access to an integrated network of road, rail and sea transport resources which stretches across the globe, the company prides itself on delivering global service with local knowledge. OUR SERVICES MSC is a world leader in global container shipping and a company offering global service with local knowledge. MSC also provides integrated network … Sectors: Transport | 548 | 331 | 151 | |
Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1621 | 945 | 333 | |
Instituto de Biomecánica (IBV) Innovation in the care of people The Instituto de Biomecánica (IBV) is a leading technological center focused on enhancing products, environments, and services for people's well-being. Founded in 1976 and concerted between the Valencian Institute for Business Competitiveness (IVACE) and the Polytechnic University of Valencia (UPV), IBV is a member of REDIT and part of the Ministerial Network of Units of Scientific Culture and Innovation (UCC+i). We combine knowledge from various sciences and disciplines and apply them to multiple sectors, aiming to improve the quality of life and increase business competitiveness through people’s well-being. Our mission is to transform scientific … | 265 | 102 | 125 |